Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension

discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Providers should ensure that governance structures are in place to review, authorise and monitor the introduction of new devices and procedures. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 Recommendations 1.1 More research is needed on alcohol-mediated perivascular renal sympathetic denervation for treating resistant hypertension before it can be used in the NHS. 1.2 This procedure should only be done as part of a formal research study and a research ethics committee needs to have approved its use. What research is needed 1.3 More research, in the form of adequately powered randomised controlled trials, is needed on: • patient selection • the number and types of antihypertensive medicine use and medication adherence • the effect of optimising antihypertensive medicines and other factors, such as lifestyle change • the effect on blood pressure and duration of any effect • quality of life (qualitative and quantitative outcomes) • complications. Why the committee
